A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

Conditions: Prostate Cancer Metastatic Interventions: Radiation: Stereotactic Ablative Body Radiotherapy (SABR); Other: 177Lu-PSMA-617; Drug: Niraparib and Abiraterone Acetate Dual Action Tablet DAT; Drug: Abiraterone Acetate; Drug: Apalutamide; Drug: Androgen Deprivation Therapy (ADT); Drug: Androgen Receptor Signalling Inhibitor (ARSI); Radiation: Local Radiotherapy; Drug: Prednisolone; Drug: Docetaxel Sponsors: University College, London; Cancer Research UK; Novartis; Janssen Pharmaceutica NV Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials